California Stem Cell Agency has $15.6 Million to Spend for Patient Assistance, But It Can't Spend It -- Yet
16-month delay projected in use of royalties, problem stems from Prop. 14 language
The California stem cell agency has $15.6 million in hand that could be used to assist needy patients in clinical trials funded by the agency, but it has been told that the cash cannot be delivered to the patients for at least 16 months.
The unfortunate situation concerns at least three members of a key, new affordability group within the Cal…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.